Soleno Therapeutics, Inc. (SLNO)
NASDAQ: SLNO · Real-Time Price · USD
44.80
-0.39 (-0.85%)
Dec 23, 2024, 2:04 PM EST - Market open
Soleno Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Selling, General & Admin | 72.7 | 13.48 | 9.84 | 10.81 | 8.76 | 6.93 | |
Research & Development | 65.77 | 25.19 | 15.27 | 21.45 | 23.19 | 16.27 | |
Operating Expenses | 138.47 | 38.67 | 25.11 | 32.26 | 31.95 | 23.2 | |
Operating Income | -138.47 | -38.67 | -25.11 | -32.26 | -31.95 | -23.2 | |
Interest & Investment Income | 10.83 | 2.58 | 0.3 | 0.11 | 0.01 | 0.15 | |
Earnings From Equity Investments | - | - | - | - | - | -0.48 | |
Other Non Operating Income (Expenses) | 0.47 | -0.18 | 0.03 | 0.51 | 11.64 | -6.96 | |
EBT Excluding Unusual Items | -127.17 | -36.27 | -24.78 | -31.64 | -20.3 | -30.49 | |
Other Unusual Items | -4 | -2.71 | 0.71 | 0.73 | -4.34 | -0.29 | |
Pretax Income | -131.16 | -38.99 | -24.07 | -30.91 | -24.64 | -30.77 | |
Earnings From Continuing Operations | -131.16 | -38.99 | -24.07 | -30.91 | -24.64 | -30.77 | |
Net Income | -131.16 | -38.99 | -24.07 | -30.91 | -24.64 | -30.77 | |
Net Income to Common | -131.16 | -38.99 | -24.07 | -30.91 | -24.64 | -30.77 | |
Shares Outstanding (Basic) | 38 | 16 | 8 | 5 | 4 | 2 | |
Shares Outstanding (Diluted) | 38 | 16 | 8 | 5 | 4 | 2 | |
Shares Change (YoY) | 271.22% | 96.40% | 57.90% | 27.39% | 83.41% | 62.77% | |
EPS (Basic) | -3.47 | -2.36 | -2.87 | -5.81 | -5.90 | -13.52 | |
EPS (Diluted) | -3.47 | -2.36 | -2.87 | -5.81 | -5.90 | -13.52 | |
Free Cash Flow | -51.63 | -24.94 | -20.79 | -27.79 | -25.23 | -17.4 | |
Free Cash Flow Per Share | -1.36 | -1.51 | -2.48 | -5.23 | -6.04 | -7.64 | |
EBITDA | -136.5 | -36.71 | -23.15 | -30.3 | -30 | -21.24 | |
D&A For EBITDA | 1.97 | 1.96 | 1.96 | 1.96 | 1.95 | 1.96 | |
EBIT | -138.47 | -38.67 | -25.11 | -32.26 | -31.95 | -23.2 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.